MCKENZIE DIANA
SEC CIK 1754648 · EDGAR
BoughtSold
Most active insiders at MET, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | DEBEL MARLENE | EVP, CRO | — | $1.74M |
| 2 | O'Neill Adrienne Karen | EVP, CAO | — | — |
| 3 | Mumenthaler Christian Stephane | Dir | — | — |
| 4 | Curtis Monica M | EVP, CLO | — | — |
| 5 | Sibblies Shurawl | EVP, Chief HR Off | — | — |
| 6 | Hay Laura J | Dir | — | — |
| 7 | Seitz Michelle | Dir | — | — |
| 8 | PAPPAS BILL | EVP, Gbl Tech, Ops | — | — |
| 9 | WEINBERGER MARK A | Dir | — | — |
| 10 | MCKENZIE DIANA | Dir | — | — |
Transactions 58
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-10 16:02 | 2026-09-08 | MET | MetLife | MCKENZIE DIANA | Dir | A - Grant | $95.50 | +157 | 25.4K | +0.6% | +$15.0K | |
| 2026-06-18 16:12 | 2026-06-16 | MET | MetLife | MCKENZIE DIANA | Dir | A - Grant | $87.40 | +587 | 25.2K | +2% | +$51.3K | |
| 2026-06-11 16:02 | 2026-06-09 | MET | MetLife | MCKENZIE DIANA | Dir | A - Grant | $85.57 | +169 | 24.6K | +0.7% | +$14.5K | |
| 2026-06-04 21:56 | 2026-06-02 | AGL | agilon health, inc. | MCKENZIE DIANA | Dir | A - Grant | $0.00 | +2,133 | 7,633 | +39% | $0 | |
| D | 2026-05-05 17:18 | 2026-05-01 | VRTX | Vertex Pharmaceuticals | MCKENZIE DIANA | Dir | A - Grant | $0.00 | +943 | 3,174 | +42% | $0 |
| D | 2026-05-05 17:18 | 2026-05-01 | VRTX | Vertex Pharmaceuticals | MCKENZIE DIANA | Dir | D - Sale to Iss | — | -796 | 2,378 | -25% | — |
| 2026-04-03 16:04 | 2026-04-01 | MET | MetLife | MCKENZIE DIANA | Dir | A - Grant | $71.17 | +721 | 24.5K | +3% | +$51.3K | |
| 2026-03-12 | 2026-03-10 | MET | MetLife | MCKENZIE DIANA | Dir | A - Grant | $70.60 | +189 | 23.8K | +0.8% | +$13.3K | |
| 2026-01-06 | 2026-01-02 | MET | MetLife | MCKENZIE DIANA | Dir | A - Grant | $80.32 | +639 | 23.6K | +3% | +$51.3K | |
| 2025-12-11 | 2025-12-09 | MET | MetLife | MCKENZIE DIANA | Dir | A - Grant | $77.82 | +166 | 22.9K | +0.7% | +$12.9K | |
| 2025-10-03 | 2025-10-01 | MET | MetLife | MCKENZIE DIANA | Dir | A - Grant | $81.93 | +534 | 22.8K | +2% | +$43.8K | |
| 2025-09-11 | 2025-09-09 | MET | MetLife | MCKENZIE DIANA | Dir | A - Grant | $79.29 | +158 | 22.2K | +0.7% | +$12.5K | |
| 2025-06-20 | 2025-06-17 | MET | MetLife | MCKENZIE DIANA | Dir | A - Grant | $77.85 | +562 | 22.1K | +3% | +$43.8K | |
| 2025-06-12 | 2025-06-10 | MET | MetLife | MCKENZIE DIANA | Dir | A - Grant | $79.43 | +153 | 21.5K | +0.7% | +$12.2K | |
| 2025-05-30 | 2025-05-28 | AGL | agilon health, inc. | MCKENZIE DIANA | Dir | A - Grant | $0.00 | +78.7K | 137.5K | +134% | $0 | |
| D | 2025-05-05 | 2025-05-01 | VRTX | Vertex Pharmaceuticals | MCKENZIE DIANA | Dir | A - Grant | $0.00 | +796 | 3,232 | +33% | $0 |
| D | 2025-05-05 | 2025-05-01 | VRTX | Vertex Pharmaceuticals | MCKENZIE DIANA | Dir | D - Sale to Iss | — | -1,001 | 2,231 | -31% | — |
| 2025-04-03 | 2025-04-01 | MET | MetLife | MCKENZIE DIANA | Dir | A - Grant | $81.16 | +540 | 21.4K | +3% | +$43.8K | |
| 2025-03-13 | 2025-03-11 | MET | MetLife | MCKENZIE DIANA | Dir | A - Grant | $78.45 | +144 | 20.8K | +0.7% | +$11.3K | |
| 2025-01-06 | 2025-01-02 | MET | MetLife | MCKENZIE DIANA | Dir | A - Grant | $81.78 | +535 | 20.7K | +3% | +$43.8K | |
| 2024-12-18 | 2024-12-16 | MET | MetLife | MCKENZIE DIANA | Dir | A - Grant | $82.74 | +132 | 20.1K | +0.7% | +$10.9K | |
| M | 2024-12-11 | 2024-11-25+ | AGL | agilon health, inc. | MCKENZIE DIANA | Dir | P - Purchase | $2.25 | +20.0K | 58.8K | +52% | +$45.0K |
| 2024-10-03 | 2024-10-01 | MET | MetLife | MCKENZIE DIANA | Dir | A - Grant | $81.78 | +535 | 20.0K | +3% | +$43.8K | |
| 2024-09-12 | 2024-09-10 | MET | MetLife | MCKENZIE DIANA | Dir | A - Grant | $74.63 | +141 | 19.5K | +0.7% | +$10.5K | |
| 2024-06-20 | 2024-06-18 | MET | MetLife | MCKENZIE DIANA | Dir | A - Grant | $69.86 | +627 | 19.3K | +3% | +$43.8K | |
| 2024-06-13 | 2024-06-11 | MET | MetLife | MCKENZIE DIANA | Dir | A - Grant | $69.06 | +146 | 18.7K | +0.8% | +$10.1K | |
| 2024-05-31 | 2024-05-29 | AGL | agilon health, inc. | MCKENZIE DIANA | Dir | A - Grant | $0.00 | +32.1K | 38.8K | +479% | $0 | |
| D | 2024-05-03 | 2024-05-01 | VRTX | Vertex Pharmaceuticals | MCKENZIE DIANA | Dir | A - Grant | $0.00 | +1,001 | 3,604 | +38% | $0 |
| D | 2024-05-03 | 2024-05-01 | VRTX | Vertex Pharmaceuticals | MCKENZIE DIANA | Dir | D - Sale to Iss | — | -1,168 | 2,436 | -32% | — |
| 2024-04-03 | 2024-04-01 | MET | MetLife | MCKENZIE DIANA | Dir | A - Grant | $73.69 | +594 | 18.6K | +3% | +$43.8K | |
| 2024-03-18 | 2024-03-14 | MET | MetLife | MCKENZIE DIANA | Dir | A - Grant | $71.90 | +129 | 18.0K | +0.7% | +$9,275 | |
| 2024-01-04 | 2024-01-02 | MET | MetLife | MCKENZIE DIANA | Dir | A - Grant | $67.35 | +650 | 17.8K | +4% | +$43.8K | |
| 2023-12-18 | 2023-12-14 | MET | MetLife | MCKENZIE DIANA | Dir | A - Grant | $66.90 | +132 | 17.2K | +0.8% | +$8,831 | |
| 2023-10-04 | 2023-10-02 | MET | MetLife | MCKENZIE DIANA | Dir | A - Grant | $61.69 | +710 | 17.0K | +4% | +$43.8K | |
| 2023-09-18 | 2023-09-14 | MET | MetLife | MCKENZIE DIANA | Dir | A - Grant | $65.93 | +128 | 16.3K | +0.8% | +$8,439 | |
| 2023-06-22 | 2023-06-20 | MET | MetLife | MCKENZIE DIANA | Dir | A - Grant | $54.52 | +803 | 16.2K | +5% | +$43.8K | |
| 2023-06-16 | 2023-06-14 | MET | MetLife | MCKENZIE DIANA | Dir | A - Grant | $53.94 | +147 | 15.4K | +1.0% | +$7,929 | |
| D | 2023-05-03 | 2023-05-01 | VRTX | Vertex Pharmaceuticals | MCKENZIE DIANA | Dir | A - Grant | $0.00 | +1,168 | 2,603 | +81% | $0 |
| D | 2023-05-03 | 2023-05-01 | VRTX | Vertex Pharmaceuticals | MCKENZIE DIANA | Dir | D - Sale to Iss | — | -1,449 | 1,435 | -50% | — |
| 2023-04-18 | 2023-04-14 | AGL | agilon health, inc. | MCKENZIE DIANA | Dir | A - Grant | $0.00 | +5,622 | 6,700 | +522% | $0 | |
| 2023-04-05 | 2023-04-03 | MET | MetLife | MCKENZIE DIANA | Dir | A - Grant | $57.97 | +755 | 15.3K | +5% | +$43.8K | |
| 2023-03-16 | 2023-03-14 | MET | MetLife | MCKENZIE DIANA | Dir | A - Grant | $59.07 | +121 | 14.5K | +0.8% | +$7,147 | |
| 2023-03-02 | 2023-02-28 | MET | MetLife | MCKENZIE DIANA | Dir | A - Grant | $71.73 | +31 | 14.4K | +0.2% | +$2,224 | |
| D | 2023-02-22 | 2023-02-17 | AGL | agilon health, inc. | MCKENZIE DIANA | Dir | A - Grant | $0.00 | +1,078 | 1,078 | New | $0 |
| 2023-01-05 | 2023-01-03 | MET | MetLife | MCKENZIE DIANA | Dir | A - Grant | $72.15 | +520 | 14.3K | +4% | +$37.5K | |
| 2022-12-16 | 2022-12-14 | MET | MetLife | MCKENZIE DIANA | Dir | A - Grant | $72.84 | +94 | 13.8K | +0.7% | +$6,847 | |
| 2022-10-05 | 2022-10-03 | MET | MetLife | MCKENZIE DIANA | Dir | A - Grant | $62.62 | +599 | 13.7K | +5% | +$37.5K | |
| 2022-09-16 | 2022-09-14 | MET | MetLife | MCKENZIE DIANA | Dir | A - Grant | $66.41 | +98 | 13.1K | +0.8% | +$6,508 | |
| 2022-06-23 | 2022-06-21 | MET | MetLife | MCKENZIE DIANA | Dir | A - Grant | $62.53 | +600 | 13.0K | +5% | +$37.5K | |
| 2022-06-16 | 2022-06-14 | MET | MetLife | MCKENZIE DIANA | Dir | A - Grant | $61.86 | +100 | 12.4K | +0.8% | +$6,186 | |
| D | 2022-05-03 | 2022-05-01 | VRTX | Vertex Pharmaceuticals | MCKENZIE DIANA | Dir | A - Grant | $0.00 | +1,449 | 2,884 | +101% | $0 |
| D | 2022-05-03 | 2022-05-01 | VRTX | Vertex Pharmaceuticals | MCKENZIE DIANA | Dir | D - Sale to Iss | — | -1,842 | 1,435 | -56% | — |
| 2022-04-05 | 2022-04-01 | MET | MetLife | MCKENZIE DIANA | Dir | A - Grant | $70.50 | +532 | 12.3K | +5% | +$37.5K | |
| 2022-03-16 | 2022-03-14 | MET | MetLife | MCKENZIE DIANA | Dir | A - Grant | $64.69 | +87 | 11.8K | +0.7% | +$5,628 | |
| 2022-01-05 | 2022-01-03 | MET | MetLife | MCKENZIE DIANA | Dir | A - Grant | $63.23 | +594 | 11.7K | +5% | +$37.6K | |
| 2021-12-16 | 2021-12-14 | MET | MetLife | MCKENZIE DIANA | Dir | A - Grant | $60.80 | +87 | 11.1K | +0.8% | +$5,290 | |
| 2021-10-05 | 2021-10-01 | MET | MetLife | MCKENZIE DIANA | Dir | A - Grant | $62.52 | +600 | 11.0K | +6% | +$37.5K | |
| 2021-09-16 | 2021-09-14 | MET | MetLife | MCKENZIE DIANA | Dir | A - Grant | $60.78 | +82 | 10.4K | +0.8% | +$4,984 |
Purchase Sale Sale after option exercise All abbreviations